Floatz logo

Voriconazole

Infection

Medical College of WisconsinSmall moleculePhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Infection cohort.

Asset / SponsorPhaseRating
SULFAMETHOXAZOLE
Radboud University Medical Center
Phase 4A
Trimethoprim
Radboud University Medical Center
Phase 4A
Ciprofloxacin
Radboud University Medical Center
Phase 4BBB
Fosfomycin
Radboud University Medical Center
Phase 4BB
Aztreonam
Liverpool Heart and Chest Hospital NHS Foundation Trust
Phase 4BB

View all 50 →

Same molecule, other indications

Voriconazole is also rated in:

fungal infectious diseaseDormant
B
Indicative ·
63 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
62 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →